Bottom line: if you're supplementing carnitine & feeling unexplained fatigue/brain fog, this could be why.
Your thyroid isn't broken, it's being chemically cockblocked
Most ppl think carnitine is just for fat burning.
Wrong.
It's quietly sabotaging your thyroid function at the cellular level & your bloodwork won't show it.
ALCAR is different tho. One study shows it might mess w/ hormone synthesis itself (iodine complexation), not just nuclear transport.
Different mechanism, same shitty outcome.
Almost 500 papers in the entire field.
I've surveyed them ALL in my Bioregulators course.
Join The OptiLab Engine today (link in bio) and start learning that some bioregulators do indeed have more evidence than most peptides and research molecules.
-53 compounds total.
-A Cochrane Independent WESTERN Systematic Review.
-A true Placebo-Controlled RCT
-3 long observational cohorts (ONE BEING OVER 15 YEARS!!!)
-1,115-patient multicenter program with Prostatilen, 979 in CORTEX, 498-patient in Retinalamin.
-Multi-Continental replication of core findings.
-5 randomized open label trials
Papers still being published, last one came out this year actually. The field is GROWING and YouTubers and influencer wannabees simply do not read the literature we have.
In severe COVID, a thymus peptide preparation dropped mortality to 20.6% versus 40.9% on standard care. Anti-inflammatory AND immune-building simultaneously.
Your thymus is quietly turning into fat. The organ that trains your immune system's T-cells starts shrinking in your twenties. By 60, most functional tissue is gone.
No functioning thymus means your body stops producing new immune cells. You're running on the same batch from decades ago, and they're wearing out.
Most immune interventions either stimulate or suppress. Thymalin appears to do both by restoring the regulatory infrastructure that decides which direction to go.
This is what makes the bioregulator paradigm different from pharmaceuticals. Not overriding a system. Restoring the decision-making architecture underneath it.
A thymus-derived peptide outperformed a major pharmaceutical immunosuppressant in severe COVID mortality. 258 patients. Three groups. The numbers are striking.